NCT05750641

Brief Summary

The goal of this observational study is to learn about compare the effect of removing animal milk from diets on the symptoms of FD patients in describe participant population. The main question it aims to answer are:

  • Can removing milk and dairy from diets be used to treat FD patients? The participants will be divided into two groups and will do the following;
  • removing milk and dairy products under the advice of a dietician without medical treatment
  • receiving medical treatment without restricted diet. Researchers will compare two groups to the effect of removing milk from diet on the symptoms of FD patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2021

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

February 20, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 2, 2023

Completed
Last Updated

March 2, 2023

Status Verified

February 1, 2023

Enrollment Period

7 months

First QC Date

February 20, 2023

Last Update Submit

February 20, 2023

Conditions

Keywords

functional dyspepsiamilkdairy products

Outcome Measures

Primary Outcomes (1)

  • The comparing the scores of symptom subsets of the two patient groups

    Gastrointestinal Symptom Rating Scale

    one month

Study Arms (2)

diet group

those who removed milk and dairy products under the advice of a dietician without medical treatment.

Other: removing milk and dairy products from diets without medical treatment

free-diet group

According to current standard algorithms and guidelines, appropriate treatment for FD types was arranged for the patient group who preferred to receive a free diet.

Other: According to current standard algorithms and guidelines, appropriate treatment for FD types.

Interventions

A specialist dietician prepared a diet list based on providing adequate balanced nutrition and is handed over to the diet group without any medical treatment

diet group

According to current standard algorithms and guidelines, appropriate treatment for FD types was arranged for the patient group who preferred to receive a free diet

free-diet group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients between the ages of 18-65 admitted to the gastroenterology outpatient clinic between September 2020 and March 2021, fulfilling the Rome IV Consensus criteria for the diagnosis of FD, were included in the study in a cross-sectional and prospective manner according to the order of admission

You may qualify if:

  • between the ages of 18-65
  • having at least one of the complaints of postprandial fullness, early satiety, epigastric burning and pain
  • the onset of the complaint is at least 6 months ago and at least one complaint has been going on at least 3 days a week for the last 3 months
  • no underlying organic pathology is detected in the examinations.

You may not qualify if:

  • being outside the age range of 18-65
  • having alarm symptoms such as vomiting, gastrointestinal bleeding, and weight loss of 5% or more in the last 3 months
  • presence of comorbidities such as dementia, CVD, psychiatric diseases
  • covid-19 positivity during the research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bezmialem Vakif Univercity

Istanbul, 34093, Turkey (Türkiye)

Location

MeSH Terms

Conditions

DyspepsiaDigestive System Diseases

Interventions

Guidelines as Topic

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Quality Assurance, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2023

First Posted

March 2, 2023

Study Start

September 1, 2020

Primary Completion

March 31, 2021

Study Completion

April 30, 2021

Last Updated

March 2, 2023

Record last verified: 2023-02

Locations